On October 28th Dr Reddy’s laboratories stock price declined around 2.91%.
After the whole pharma sector reported a major decline from the year to year basis in the September quarter.
The company had a profit of more than Rs.1000 crores and it straight away declined to Rs.762 crores but it increased Rs.32 crore sequentially.
There was also an increase in quarter to quarter with a total of 2 per cent.
Disadvantages of having loss or decreasing the share prices are:
Declining in net profit and declining in quarterly net profit with falling profit margin.
The company has reported a decline in quarterly net profit with a falling profit margin (YoY).
In these difficult times there is always sometimes a profit and sometimes loss but at the end everything will fall in line slowly and gradually.
Check all Recent News Updates Here
|Today’s News Update|